«Standard of care and outlook for treatment modalities in GI malignancies»

Thursday, 3rd December 2020, 3:15 – 6:00 pm in Zurich, Hotel St. Gotthard

If the login button does not work.
Please try with another web browser or write an email. Thanks for your understanding.

Dear colleagues,

We invite you again this year to participate in an interactive exchange of information on the extended use of known markers and new procedures in the field of gastrointestinal tumors.

The medical progress in oncology is rapidly evolving. With the therapeutic expansion through targeted medicine, immune oncology has also seen an improvement in the treatment of these tumor diseases in recent years. In addition to therapeutic progress, the possibilities in diagnostics have also made great strides. Thus, in addition to the known predictive and prognostic markers, new procedures such as NGS analysis or methods for measuring «tumor burden» or ctDNA are no longer used solely for scientific purposes.


We would be very pleased if you could send us a patient case, a topic that interests you or questions in advance. We are very interested in responding to your needs in this education and discussing the individual cases together.


We would be very pleased to welcome participants from all language regions of Switzerland on this occasion.

With kind regards,

Dr. med. A. Siebenhüner

University Hospital Zurich

Dr. med. Sara De Dosso

Regional Hospital of Bellinzona

PD Dr. med. Dr. phil. A. Wicki
Cantonal Hospital Baselland

PD Dr. med. univ. T. Winder

Swiss Tumor Molecular Institute

This advanced education is supported by: